shikonin and arginyl-glycyl-aspartic-acid

shikonin has been researched along with arginyl-glycyl-aspartic-acid* in 1 studies

Other Studies

1 other study(ies) available for shikonin and arginyl-glycyl-aspartic-acid

ArticleYear
Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells.
    Molecules (Basel, Switzerland), 2018, Jan-29, Volume: 23, Issue:2

    Shikonin (SHK) has been proven to have a good anti-tumor effect. However, poor water solubility and low bioavailability limit its wide application in clinical practice. In this study, to overcome these drawbacks, RGD-modified shikonin-loaded liposomes (RGD-SSLs-SHK) were successfully prepared. It exhibited excellent physicochemical characteristics including particle size, zeta potential, encapsulation efficiency, and delayed release time. Meanwhile, the targeting activity of the RGD-modified liposomes was demonstrated by flow cytometry and confocal microscopy in the α

    Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Adhesion; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Liposomes; MCF-7 Cells; Naphthoquinones; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Transcription Factor RelA

2018